Lab Power | Predictions for 2025

As 2025 approaches, the healthcare landscape is undergoing rapid transformation. Rising healthcare utilization, escalating costs and surging demand for specialized drugs like GLP-1 [glucagon-like peptide 1] therapies are intensifying the need for innovative solutions. One critical strategy lies in harnessing the power of lab data.

Kerr

By leveraging comprehensive lab insights, payers and employers can identify patients eligible for targeted treatments, stratify them by risk and ensure that costly medications are prescribed judiciously. This data-driven approach not only helps manage expenses but also improves patient outcomes.